The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG)

Autor: Saskia Van der Oord, Chris Hollis, Samuele Cortese, Cesar Soutullo, Philip Asherson, Edmund J.S. Sonuga-Barke, Santosh Paramala, Daniel Brandeis, Emily Simonoff, Marina Danckaerts, Ian C. K. Wong, David Daley, Tobias Banaschewski, Maite Ferrin, Alessandro Zuddas, Martin Holtmann, Manfred Doepfner, Ralf W. Dittmann, Hans-Christoph Steinhausen, David Coghill, Jan K. Buitelaar
Přispěvatelé: University of Zurich, Simonoff, Emily
Jazyk: angličtina
Rok vydání: 2023
Předmět:
NEUROPSYCHOLOGICAL OUTCOMES
Psychological intervention
Social Sciences
Psychology
Developmental
YOUNG-PEOPLE
Review
Guideline
Pediatrics
2738 Psychiatry and Mental Health
DEFICIT-HYPERACTIVITY DISORDER
LISDEXAMFETAMINE DIMESYLATE
Health care
Developmental and Educational Psychology
Child and adolescent psychiatry
Psychology
10064 Neuroscience Center Zurich
media_common
Evidence
Psychiatry
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
based medicine
General Medicine
10058 Department of Child and Adolescent Psychiatry
Psychiatry and Mental health
10076 Center for Integrative Human Physiology
Life Sciences & Biomedicine
medicine.medical_specialty
Evidence-based medicine
RANDOMIZED CONTROLLED-TRIALS
media_common.quotation_subject
610 Medicine & health
Intervention
Attention deficit hyperactivity disorder
MEDICATION
medicine
2735 Pediatrics
Perinatology and Child Health
METAANALYSIS
Selection bias
3204 Developmental and Educational Psychology
Science & Technology
business.industry
medicine.disease
EFFICACY
Mental health
METHYLPHENIDATE
Pediatrics
Perinatology and Child Health
Observational study
business
Zdroj: European Child & Adolescent Psychiatry, 32 (8)
European Child & Adolescent Psychiatry
ISSN: 1435-165X
1018-8827
Popis: ADHD is the most common neurodevelopmental disorder presenting to child and adolescent mental health, paediatric, and primary care services. Timely and effective interventions to address core ADHD symptoms and co-occurring problems are a high priority for healthcare and society more widely. While much research has reported on the benefits and adverse effects of different interventions for ADHD, these individual research reports and the reviews, meta-analyses and guidelines summarizing their findings are sometimes inconsistent and difficult to interpret. We have summarized the current evidence and identified several methodological issues and gaps in the current evidence that we believe are important for clinicians to consider when evaluating the evidence and making treatment decisions. These include understanding potential impact of bias such as inadequate blinding and selection bias on study outcomes; the relative lack of high-quality data comparing different treatments and assessing long-term effectiveness, adverse effects and safety for both pharmacological and non-pharmacological treatments; and the problems associated with observational studies, including those based on large national registries and comparing treatments with each other. We highlight key similarities across current international clinical guidelines and discuss the reasons for divergence where these occur. We discuss the integration of these different perspective into a framework for person/family-centered evidence-based practice approach to care that aims to achieve optimal outcomes that prioritize individual strengths and impairments, as well as the personal treatment targets of children and their families. Finally, we consider how access to care for this common and impairing disorder can be improved in different healthcare systems.
European Child & Adolescent Psychiatry, 32 (8)
ISSN:1435-165X
ISSN:1018-8827
Databáze: OpenAIRE
Externí odkaz: